praliciguat
praliciguat: 1 clinical trial tracked.
praliciguat evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about praliciguat, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Praliciguat in Patients With Biopsy-Confirmed Focal Segmental Glomerulosclerosis
Primary endpoint: Change from Baseline in urine protein-to-creatinine ratio (UPCR) (Part A)
InterventionalRandomizedtriple60 targetStarted 2025-12Completion 2028-0130 sites · United StatesAkebia Therapeutics